Balance Sheet FP Corporation

Stocks

7947

JP3167000003

Non-Paper Containers & Packaging

Market Closed - Japan Exchange Other stock markets 12:00:00 10/07/2026 pm IST			5-day change	1st Jan Change
2,519.00 ^JPY	-1.06%		-4.11%	-4.22%

21/05	Fp Corporation Announces Approves Dividend for the Fiscal Year Ended March 31, 2026, Payable on June 8, 2026	CI
30/04	FP Corporation Reports Earnings Results for the Full Year Ended March 31, 2026	CI

c3b7923c0e5704a91b5.ckUjVe9SxatStxQWcMuxyBpVhyxxtyWFMG6_QnbfzU8.EQpkHaAxgMcr-2FSFYbE_Vgh0UI_wBfoVUPPFhKzvRcHAGFtwgaSngWFRQ

Published financial data: FP CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2022	2023	2024	2025	2026
Revenues	20TCr	21TCr	22TCr	24TCr	24TCr
Total Revenues	20TCr	21TCr	22TCr	24TCr	24TCr
Cost of Goods Sold, Total	13TCr	15TCr	16TCr	16TCr	16TCr
Gross Profit	6.27TCr	6.55TCr	6.71TCr	7.31TCr	7.84TCr
Selling General & Admin Expenses, Total	4.31TCr	4.48TCr	4.62TCr	5.03TCr	5.25TCr
Provision for Bad Debts	-90L	-1.1Cr	-1Cr	-1.2Cr	30L
Depreciation & Amortization - (IS)	373.4Cr	399.9Cr	443.6Cr	434.2Cr	430.1Cr
Other Operating Expenses, Total	4.68TCr	4.88TCr	5.07TCr	5.46TCr	5.68TCr
Operating Income	1.59TCr	1.67TCr	1.64TCr	1.85TCr	2.16TCr
Interest Expense, Total	-6.9Cr	-14Cr	-16Cr	-20Cr	-33Cr
Interest And Investment Income	12Cr	11Cr	8.2Cr	10Cr	11Cr
Net Interest Expenses	4.7Cr	-2.7Cr	-7.6Cr	-9.7Cr	-22Cr
Income (Loss) On Equity Invest.	5.1Cr	7.1Cr	-20Cr	-34Cr	-7.9Cr
Other Non Operating Income (Expenses)	62Cr	41Cr	49Cr	25Cr	22Cr
EBT, Excl. Unusual Items	1.66TCr	1.71TCr	1.66TCr	1.83TCr	2.15TCr
Gain (Loss) On Sale Of Investments	-2.1Cr	35Cr	21Cr	35Cr	10Cr
Gain (Loss) On Sale Of Assets	5.8Cr	-56Cr	13Cr	-31Cr	-18Cr
Asset Writedown	-222.9Cr	-	-69Cr	-3.7Cr	-
Other Unusual Items	206.6Cr	-	70Cr	-	-
EBT, Incl. Unusual Items	1.65TCr	1.69TCr	1.7TCr	1.83TCr	2.15TCr
Income Tax Expense	515.3Cr	532.4Cr	525.2Cr	579.3Cr	651Cr
Earnings From Continuing Operations	1.13TCr	1.16TCr	1.17TCr	1.25TCr	1.49TCr
Net Income to Company	1.13TCr	1.16TCr	1.17TCr	1.25TCr	1.49TCr
Minority Interest	-9.8Cr	-7.6Cr	-70L	-60L	-7.7Cr
Net Income - (IS)	1.12TCr	1.15TCr	1.17TCr	1.25TCr	1.49TCr
Net Income to Common Incl Extra Items	1.12TCr	1.15TCr	1.17TCr	1.25TCr	1.49TCr
Net Income to Common Excl. Extra Items	1.12TCr	1.15TCr	1.17TCr	1.25TCr	1.49TCr
Per Share Items
Net EPS - Basic	136.95	140.87	143.5	154.45	183.87
Basic EPS - Continuing Operations	136.95	140.87	143.5	154.45	183.87
Basic Weighted Average Shares Outstanding	8.18Cr	8.18Cr	8.17Cr	8.08Cr	8.09Cr
Net EPS - Diluted	136.95	140.87	143.5	154.45	183.87
Diluted EPS - Continuing Operations	136.95	140.87	143.5	154.45	183.87
Diluted Weighted Average Shares Outstanding	8.18Cr	8.18Cr	8.17Cr	8.08Cr	8.09Cr
Normalized Basic EPS	125.47	129.98	127.12	141.29	165.5
Normalized Diluted EPS	125.47	129.98	127.12	141.29	165.5
Dividend Per Share	47	47	57	61.5	73
Payout Ratio	33.22	33.35	32.8	36.88	38.86
Supplemental Items
EBITDA	2.95TCr	3.09TCr	3.15TCr	3.32TCr	3.62TCr
EBITA	1.59TCr	1.67TCr	1.64TCr	1.85TCr	2.16TCr
EBIT	1.59TCr	1.67TCr	1.64TCr	1.85TCr	2.16TCr
Effective Tax Rate - (Ratio)	31.31	31.45	30.92	31.68	30.34
Normalized Net Income	1.03TCr	1.06TCr	1.04TCr	1.14TCr	1.34TCr
Non-Cash Pension Expense	69Cr	50Cr	42Cr	40Cr	33Cr
Supplemental Operating Expense Items
Advertising Expense	-	-	-	-	-
Selling and Marketing Expenses	1.86TCr	1.84TCr	1.91TCr	2.05TCr	2.09TCr
General and Administrative Expenses	78Cr	84Cr	95Cr	97Cr	98Cr
Research And Development Expense From Footnotes	115.4Cr	129.5Cr	148.3Cr	154.3Cr	190.3Cr

Fiscal Period: March	2022	2023	2024	2025	2026
Assets
Cash And Equivalents	1.97TCr	2.23TCr	2.37TCr	1.9TCr	2.55TCr
Total Cash And Short Term Investments	1.97TCr	2.23TCr	2.37TCr	1.9TCr	2.55TCr
Accounts Receivable, Total	3.89TCr	4.2TCr	4.73TCr	4.26TCr	4.22TCr
Other Receivables	387.2Cr	662.5Cr	483.6Cr	469Cr	422.4Cr
Total Receivables	4.28TCr	4.86TCr	5.21TCr	4.73TCr	4.64TCr
Inventory	2.43TCr	2.99TCr	2.89TCr	3.17TCr	3.27TCr
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	69Cr	70Cr	79Cr	86Cr	87Cr
Total Current Assets	8.75TCr	10TCr	11TCr	9.88TCr	11TCr
Net Property Plant And Equipment	16TCr	18TCr	17TCr	17TCr	18TCr
Long-term Investments	581.4Cr	1.21TCr	1.29TCr	1.21TCr	1.38TCr
Goodwill	41Cr	22Cr	70Cr	56Cr	49Cr
Other Intangibles, Total	121.6Cr	153.6Cr	289.2Cr	269.5Cr	272.2Cr
Deferred Tax Assets Long-Term	394.2Cr	406.7Cr	388.4Cr	434.6Cr	439Cr
Other Long-Term Assets, Total	10L	10L	10L	20L	10L
Total Assets	26TCr	30TCr	30TCr	29TCr	30TCr
Liabilities
Accounts Payable, Total	2.39TCr	2.65TCr	2.89TCr	2.81TCr	2.66TCr
Accrued Expenses, Total	293.4Cr	317.8Cr	334.5Cr	361.4Cr	377.3Cr
Short-term Borrowings	3.21TCr	3.29TCr	3.24TCr	3.28TCr	3.37TCr
Current Portion of Leases	114.4Cr	103.1Cr	90Cr	84Cr	91Cr
Current Income Taxes Payable	964Cr	1.47TCr	1.48TCr	1.24TCr	1.42TCr
Other Current Liabilities	707.4Cr	555.4Cr	586.5Cr	674.8Cr	697.9Cr
Total Current Liabilities	7.68TCr	8.39TCr	8.62TCr	8.44TCr	8.62TCr
Long-Term Debt	4.6TCr	6.73TCr	5.89TCr	4.62TCr	4.52TCr
Long-Term Leases	86Cr	82Cr	61Cr	73Cr	82Cr
Pension & Other Post Retirement Benefits	604Cr	536.5Cr	556.2Cr	538.6Cr	525.5Cr
Deferred Tax Liability Non Current	-	-	36Cr	34Cr	33Cr
Other Non Current Liabilities	50Cr	113.9Cr	111.7Cr	109.2Cr	111.2Cr
Total Liabilities	13TCr	16TCr	15TCr	14TCr	14TCr
Common Stock, Total	1.32TCr	1.32TCr	1.32TCr	1.32TCr	1.32TCr
Additional Paid In Capital	1.55TCr	1.56TCr	1.56TCr	1.56TCr	1.56TCr
Retained Earnings	11TCr	12TCr	12TCr	13TCr	14TCr
Treasury Stock	-556.1Cr	-553.1Cr	-848.3Cr	-841.8Cr	-835.9Cr
Comprehensive Income and Other	118.2Cr	113.5Cr	188.9Cr	220.7Cr	406.6Cr
Total Common Equity	13TCr	14TCr	15TCr	15TCr	16TCr
Minority Interest	70Cr	74Cr	71Cr	68Cr	73Cr
Total Equity	13TCr	14TCr	15TCr	15TCr	17TCr
Total Liabilities And Equity	26TCr	30TCr	30TCr	29TCr	30TCr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	8.18Cr	8.18Cr	8.08Cr	8.09Cr	8.09Cr
ECS Total Common Shares Outstanding	8.18Cr	8.18Cr	8.08Cr	8.09Cr	8.09Cr
Book Value / Share	1.61T	1.7T	1.8T	1.9T	2.03T
Tangible Book Value	13TCr	14TCr	14TCr	15TCr	16TCr
Tangible Book Value Per Share	1.59T	1.68T	1.75T	1.86T	1.99T
Total Debt	8.02TCr	10TCr	9.28TCr	8.05TCr	8.06TCr
Net Debt	6.04TCr	7.98TCr	6.91TCr	6.15TCr	5.51TCr
Debt Equivalent of Unfunded Proj. Benefit Obligation	519.2Cr	513.9Cr	531.5Cr	511Cr	500.1Cr
Minority Interest, Total (Incl. Fin. Div)	70Cr	74Cr	71Cr	68Cr	73Cr
Inventories - Raw Materials, Total	359.4Cr	502.4Cr	491.3Cr	551.4Cr	624.3Cr
Inventories - Work In Process, Total	11Cr	12Cr	14Cr	15Cr	14Cr
Inventories - Finished Goods, Total	2.06TCr	2.47TCr	2.38TCr	2.6TCr	2.63TCr
Full Time Employees	4.79T	4.88T	5.1T	5.25T	5.31T
Accumulated Allowance for Doubtful Accounts (Supple)	2.7Cr	2.8Cr	3.4Cr	2.2Cr	2.3Cr

Fiscal Period: March	2022	2023	2024	2025	2026
Net Income	1.65TCr	1.69TCr	1.7TCr	1.83TCr	2.15TCr
Depreciation & Amortization - CF	1.36TCr	1.42TCr	1.51TCr	1.48TCr	1.46TCr
Depreciation & Amortization, Total	1.36TCr	1.42TCr	1.51TCr	1.48TCr	1.46TCr
(Gain) Loss From Sale Of Asset	229.6Cr	74Cr	70Cr	47Cr	31Cr
(Gain) Loss on Sale of Investments - (CF)	-	-35Cr	-	-35Cr	-
(Income) Loss On Equity Investments - (CF)	-5.1Cr	-7.1Cr	20Cr	34Cr	7.9Cr
Other Operating Activities, Total	-507.7Cr	-440Cr	-575.8Cr	-512.3Cr	-656Cr
Change In Accounts Receivable	-214.4Cr	-303.6Cr	-512.1Cr	488.4Cr	43Cr
Change In Inventories	-188.4Cr	-557.4Cr	136.9Cr	-273.9Cr	-98Cr
Change In Accounts Payable	191Cr	53Cr	629.2Cr	-418.2Cr	-44Cr
Change in Other Net Operating Assets	-199.6Cr	112.3Cr	-54Cr	158.8Cr	109.1Cr
Cash from Operations	2.31TCr	2.01TCr	2.92TCr	2.79TCr	3TCr
Capital Expenditure	-2.32TCr	-2.78TCr	-1.14TCr	-1.48TCr	-1.6TCr
Sale of Property, Plant, and Equipment	74Cr	44Cr	77Cr	9.5Cr	-
Cash Acquisitions	-	-696.4Cr	-31Cr	-	-
Sale (Purchase) of Intangible assets	-30Cr	-57Cr	-45Cr	-53Cr	-52Cr
Investment in Marketable and Equity Securities, Total	-	76Cr	30Cr	48Cr	16Cr
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-	-	-	-
Other Investing Activities, Total	-6.3Cr	-20Cr	32Cr	-15Cr	-22Cr
Cash from Investing	-2.29TCr	-3.43TCr	-1.07TCr	-1.49TCr	-1.66TCr
Short Term Debt Issued, Total	-	-	-	-	-
Long-Term Debt Issued, Total	2.4TCr	3.8TCr	600Cr	200Cr	1.55TCr
Total Debt Issued	2.4TCr	3.8TCr	600Cr	200Cr	1.55TCr
Short Term Debt Repaid, Total	-	-	-	-6Cr	-
Long-Term Debt Repaid, Total	-1.71TCr	-1.6TCr	-1.49TCr	-1.43TCr	-1.55TCr
Total Debt Repaid	-1.71TCr	-1.6TCr	-1.49TCr	-1.43TCr	-1.55TCr
Repurchase of Common Stock	-	-	-305Cr	-	-
Common Dividends Paid	-372.3Cr	-384.5Cr	-384.6Cr	-460.5Cr	-577.8Cr
Common & Preferred Stock Dividends Paid	-372.3Cr	-384.5Cr	-384.6Cr	-460.5Cr	-577.8Cr
Other Financing Activities, Total	-157.3Cr	-140.5Cr	-122.2Cr	-113.1Cr	-110.8Cr
Cash from Financing	157.8Cr	1.67TCr	-1.7TCr	-1.81TCr	-692.8Cr
Miscellaneous Cash Flow Adjustments	-	-	-10L	39Cr	-10L
Net Change in Cash	186Cr	251Cr	145.1Cr	-468.6Cr	645.8Cr
Supplemental Items
Cash Interest Paid	6.8Cr	13Cr	16Cr	22Cr	35Cr
Cash Income Tax Paid (Refund)	710.2Cr	440.3Cr	576.6Cr	519.1Cr	657.6Cr
Levered Free Cash Flow	-439.49Cr	-883.25Cr	1.37TCr	1.07TCr	1.2TCr
Unlevered Free Cash Flow	-435.18Cr	-874.69Cr	1.38TCr	1.08TCr	1.22TCr
Change In Net Working Capital	435.8Cr	501.2Cr	-32Cr	16Cr	-66Cr
Net Debt Issued / Repaid	687.4Cr	2.2TCr	-889.5Cr	-1.23TCr	-4.2Cr

Fiscal Period: March	2022	2023	2024	2025	2026
Profitability
Return on Assets	3.89	3.72	3.43	3.91	4.53
Return on Total Capital	4.82	4.59	4.27	4.88	5.62
Return On Equity %	8.78	8.51	8.2	8.33	9.36
Return on Common Equity	8.75	8.5	8.24	8.36	9.36
Margin Analysis
Gross Profit Margin %	32.02	30.98	30.21	31.01	32.61
SG&A Margin	22.01	21.2	20.82	21.33	21.83
EBITDA Margin %	15.08	14.61	14.17	14.1	15.06
EBITA Margin %	8.11	7.9	7.39	7.84	8.99
EBIT Margin %	8.11	7.9	7.39	7.84	8.99
Income From Continuing Operations Margin %	5.78	5.49	5.28	5.3	6.21
Net Income Margin %	5.73	5.46	5.28	5.3	6.18
Net Avail. For Common Margin %	5.73	5.46	5.28	5.3	6.18
Normalized Net Income Margin	5.25	5.03	4.68	4.85	5.57
Levered Free Cash Flow Margin	-2.25	-4.18	6.18	4.52	5
Unlevered Free Cash Flow Margin	-2.22	-4.14	6.23	4.58	5.09
Asset Turnover
Asset Turnover	0.77	0.75	0.74	0.8	0.81
Fixed Assets Turnover	1.23	1.23	1.26	1.36	1.37
Receivables Turnover (Average Receivables)	5.18	5.23	4.98	5.24	5.67
Inventory Turnover (Average Inventory)	5.7	5.39	5.28	5.37	5.03
Short Term Liquidity
Current Ratio	1.14	1.21	1.22	1.17	1.22
Quick Ratio	0.81	0.84	0.88	0.79	0.83
Operating Cash Flow to Current Liabilities	0.3	0.24	0.34	0.33	0.35
Days Sales Outstanding (Average Receivables)	70.52	69.85	73.54	69.61	64.32
Days Outstanding Inventory (Average Inventory)	64.03	67.75	69.37	68.02	72.51
Average Days Payable Outstanding	60.96	60.77	65.83	62.86	61.17
Cash Conversion Cycle (Average Days)	73.59	76.83	77.08	74.77	75.66
Long Term Solvency
Total Debt/Equity	60.53	72.77	63.62	52.24	48.81
Total Debt / Total Capital	37.71	42.12	38.88	34.32	32.8
LT Debt/Equity	35.4	48.56	40.79	30.44	27.84
Long-Term Debt / Total Capital	22.05	28.11	24.93	20	18.71
Total Liabilities / Total Assets	49.58	53.06	51.15	47.26	45.68
EBIT / Interest Expense	229.94	121.79	103.87	93.29	65.7
EBITDA / Interest Expense	427.57	225.29	199.13	167.79	110.06
(EBITDA - Capex) / Interest Expense	90.67	22.56	127.28	92.9	61.39
Total Debt / EBITDA	2.72	3.3	2.95	2.42	2.23
Net Debt / EBITDA	2.05	2.58	2.2	1.85	1.52
Total Debt / (EBITDA - Capex)	12.82	33	4.61	4.38	3.99
Net Debt / (EBITDA - Capex)	9.66	25.8	3.43	3.34	2.73
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-0.63	7.96	5.12	6.09	2.06
Gross Profit, 1 Yr. Growth %	-10.09	4.45	2.48	8.92	7.32
EBITDA, 1 Yr. Growth %	-8.87	4.62	1.94	5.59	8.99
EBITA, 1 Yr. Growth %	-15.44	5.16	-1.64	12.56	17.01
EBIT, 1 Yr. Growth %	-15.44	5.16	-1.64	12.56	17.01
Earnings From Cont. Operations, 1 Yr. Growth %	-8.15	2.66	1.09	6.49	19.64
Net Income, 1 Yr. Growth %	-8.23	2.88	1.69	6.5	19.09
Normalized Net Income, 1 Yr. Growth %	-14.02	3.62	-2.37	9.97	17.17
Diluted EPS Before Extra, 1 Yr. Growth %	-7.33	2.86	1.87	7.63	19.05
Accounts Receivable, 1 Yr. Growth %	5.87	7.94	12.64	-9.9	-1.02
Inventory, 1 Yr. Growth %	8.41	22.96	-3.18	9.61	3.23
Net Property, Plant and Equip., 1 Yr. Growth %	5.96	9.44	-3.66	0.54	2.04
Total Assets, 1 Yr. Growth %	6.25	13.68	-0.01	-2.13	4.05
Tangible Book Value, 1 Yr. Growth %	6.41	5.8	2.81	6.1	7.36
Common Equity, 1 Yr. Growth %	5.96	5.82	4.09	5.72	7.18
Cash From Operations, 1 Yr. Growth %	-27.24	-13.29	45.36	-4.31	7.39
Capital Expenditures, 1 Yr. Growth %	34.22	19.48	-59.13	30.62	7.98
Levered Free Cash Flow, 1 Yr. Growth %	-143.12	100.97	-255.45	-22.35	12.82
Unlevered Free Cash Flow, 1 Yr. Growth %	-142.49	101	-258.1	-22.01	13.43
Dividend Per Share, 1 Yr. Growth %	5.62	0	21.28	7.89	18.7
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	2.48	3.58	6.53	5.6	4.06
Gross Profit, 2 Yr. CAGR %	-0.35	-3.09	3.46	5.65	8.12
EBITDA, 2 Yr. CAGR %	0.79	-2.36	3.27	3.75	7.28
EBITA, 2 Yr. CAGR %	1.15	-5.7	1.7	5.22	14.77
EBIT, 2 Yr. CAGR %	1.15	-5.7	1.7	5.22	14.77
Earnings From Cont. Operations, 2 Yr. CAGR %	1.79	-2.89	1.87	3.75	12.87
Net Income, 2 Yr. CAGR %	1.97	-2.83	2.29	4.07	12.62
Normalized Net Income, 2 Yr. CAGR %	1.63	-5.61	0.58	3.62	13.52
Diluted EPS Before Extra, 2 Yr. CAGR %	2.5	-2.37	2.36	4.71	13.2
Accounts Receivable, 2 Yr. CAGR %	6.63	6.9	10.26	0.74	-5.57
Inventory, 2 Yr. CAGR %	4.07	15.46	9.11	3.02	6.37
Net Property, Plant and Equip., 2 Yr. CAGR %	4.06	7.69	2.68	-1.58	1.29
Total Assets, 2 Yr. CAGR %	4.08	9.9	6.61	-1.08	0.91
Tangible Book Value, 2 Yr. CAGR %	5.79	6.1	4.29	4.44	6.73
Common Equity, 2 Yr. CAGR %	5.34	5.89	4.95	4.9	6.45
Cash From Operations, 2 Yr. CAGR %	-8.7	-20.57	12.27	17.94	1.37
Capital Expenditures, 2 Yr. CAGR %	47.71	26.64	-30.12	-26.93	18.76
Levered Free Cash Flow, 2 Yr. CAGR %	-44.92	-6.91	76.75	9.87	-6.4
Unlevered Free Cash Flow, 2 Yr. CAGR %	-45.3	-7.59	78.26	11.04	-5.95
Dividend Per Share, 2 Yr. CAGR %	7.73	2.77	10.13	14.39	13.17
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	2.6	4.28	4.09	6.38	4.41
Gross Profit, 3 Yr. CAGR %	2.04	1.23	-1.27	5.25	6.21
EBITDA, 3 Yr. CAGR %	2.85	2.05	-0.94	4.04	5.47
EBITA, 3 Yr. CAGR %	4.38	2.47	-4.37	5.2	9.01
EBIT, 3 Yr. CAGR %	4.38	2.47	-4.37	5.2	9.01
Earnings From Cont. Operations, 3 Yr. CAGR %	4.27	2.08	-1.59	3.39	8.8
Net Income, 3 Yr. CAGR %	4.21	2.27	-1.35	3.67	8.85
Normalized Net Income, 3 Yr. CAGR %	4.02	2.29	-4.54	3.62	7.95
Diluted EPS Before Extra, 3 Yr. CAGR %	4.57	2.62	-0.98	4.09	9.29
Accounts Receivable, 3 Yr. CAGR %	0.34	7.06	8.78	3.08	0.15
Inventory, 3 Yr. CAGR %	2.51	10.02	8.88	9.28	3.09
Net Property, Plant and Equip., 3 Yr. CAGR %	2.24	5.82	3.76	1.96	-0.39
Total Assets, 3 Yr. CAGR %	1.76	7.19	6.49	3.61	0.6
Tangible Book Value, 3 Yr. CAGR %	6.03	5.79	4.99	4.89	5.41
Common Equity, 3 Yr. CAGR %	5.64	5.5	5.29	5.21	5.65
Cash From Operations, 3 Yr. CAGR %	-3.19	-10.26	-2.84	6.45	14.31
Capital Expenditures, 3 Yr. CAGR %	11.42	37.63	-13.13	-13.92	-16.77
Levered Free Cash Flow, 3 Yr. CAGR %	13.28	-15.2	10.44	34.37	10.84
Unlevered Free Cash Flow, 3 Yr. CAGR %	12.03	-15.59	10.52	35.33	11.83
Dividend Per Share, 3 Yr. CAGR %	5.09	5.09	8.6	9.38	15.81
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	2.51	4.01	4.16	4.8	4.08
Gross Profit, 5 Yr. CAGR %	1.84	3.29	2.61	2.97	2.39
EBITDA, 5 Yr. CAGR %	2.28	4.65	3.02	2.73	2.27
EBITA, 5 Yr. CAGR %	0.89	5.3	3.3	3.56	2.87
EBIT, 5 Yr. CAGR %	0.89	5.3	3.3	3.56	2.87
Earnings From Cont. Operations, 5 Yr. CAGR %	0.6	4.76	3.31	2.75	3.96
Net Income, 5 Yr. CAGR %	0.46	4.67	3.44	2.99	4.02
Normalized Net Income, 5 Yr. CAGR %	1.06	4.92	2.63	2.82	2.31
Diluted EPS Before Extra, 5 Yr. CAGR %	0.68	4.88	3.68	3.45	4.47
Accounts Receivable, 5 Yr. CAGR %	3.72	2.3	4.2	4.49	2.8
Inventory, 5 Yr. CAGR %	4.88	6.36	5.1	7.17	7.87
Net Property, Plant and Equip., 5 Yr. CAGR %	3.77	3.11	2.42	2.8	2.77
Total Assets, 5 Yr. CAGR %	3.66	4.11	3.67	3.8	4.22
Tangible Book Value, 5 Yr. CAGR %	6.05	5.86	5.33	5.25	5.68
Common Equity, 5 Yr. CAGR %	5.81	5.67	5.37	5.26	5.75
Cash From Operations, 5 Yr. CAGR %	-2.23	7.51	2.72	0.11	-1.18
Capital Expenditures, 5 Yr. CAGR %	0.6	3.38	-7.55	6.84	-1.56
Levered Free Cash Flow, 5 Yr. CAGR %	11.8	7.29	35.34	-5.95	3.37
Unlevered Free Cash Flow, 5 Yr. CAGR %	12.6	7.37	34.91	-5.81	3.62
Dividend Per Share, 5 Yr. CAGR %	3.28	3.02	7.07	8.71	10.41